SPRO vs TSN · P/E 9.6, rev $258.0K vs P/E 22, rev $54.44B
Spero Therapeutics Inc (SPRO) versus Tyson Foods Inc (TSN) — a side-by-side from cached financials, not a winner call.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
Tyson Foods Inc (TSN) is a farm products company listed on US.
Latest reported SPRO revenue for 2026-06-30 was $258.0K. Net income was -$16.8M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Latest reported TSN revenue for 2025-09-27 was $54.44B. Net income was $507.0M. TSN currently screens at market cap $20.43B and trailing P/E 22.3.
SPRO currently screens at market cap $149.5M and trailing P/E 9.6. TSN currently screens at market cap $20.43B and trailing P/E 22.3.
Not investment advice. Open the SPRO and TSN stock pages for the full models.
Not investment advice.